Drug Development Pharmaceutical Companies White Paper 
Pharmaceutical Technology
FEBRUARY 1, 2023
RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.
European Pharmaceutical Review
DECEMBER 21, 2022
“As the contribution of costs of organic chemicals used as feedstock to the operating expenditures is small, the pharmaceutical companies can spearhead and guide the transition.” He is currently group leader of the Technology Development and Discovery Group at the Bioprocess Laboratory of the ETH. 199‒208.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Putting Patients First Blog
JUNE 30, 2023
No mention was provided in the proposed changes nor the white paper on Advancing Health Technology Assessment Methods that Support Health Equity of clinical trial participants with differential abilities. have robust suggestions on increasing diversity in clinical trials for sponsors and drug developers.
Pharmaceutical Technology
DECEMBER 6, 2022
HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.
Pharmaceutical Technology
DECEMBER 9, 2022
Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. Brazilian public spending on healthcare, drug pricing reforms and remote medicine. . <p>Early
Pharmaceutical Technology
MARCH 22, 2023
Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. This was higher than the number of approvals in 2019 and 2020. Regulators are also paying close attention to the risks.
Pharmaceutical Technology
FEBRUARY 20, 2023
We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ)
Expert insights. Personalized for you.
64 
Let's personalize your content